Company & Sponsor Intelligence
GlaxoSmithKline
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials35
Recruiting1
Completed30
Countries11
Therapeutic footprint
adhdalzheimersanxietydepressionepilepsyother_psychiatryparkinsonsschizophrenia
Indexed studies
NCT01929317A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.
parkinsons · JapanPHASE3
parkinsons · JapanPHASE3
NCT00508911A Study To Evaluate The Effect Of GW876008 On The Pharmacokinetics Of Oral Contraceptive Pills
anxiety · United KingdomPHASE1
anxiety · United KingdomPHASE1
NCT00627575AED/Statin Interaction Study
epilepsy · United StatesPHASE1
epilepsy · United StatesPHASE1
NCT00310375Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial
epilepsy · United StatesPHASE3
epilepsy · United StatesPHASE3
NCT00555139A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder
depression · SpainPHASE1
depression · SpainPHASE1
NCT00567424GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
epilepsy · United StatesPHASE2
epilepsy · United StatesPHASE2
NCT00044278Pediatric Epilepsy Study in Subjects 1-24 Months
epilepsy · United StatesPHASE2
epilepsy · United StatesPHASE2
NCT00048360Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults
adhd · United StatesPHASE3
adhd · United StatesPHASE3
NCT01435915Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects
parkinsons · ChinaPHASE1
parkinsons · ChinaPHASE1
NCT00579982An Open-Label Trial Measuring Satisfaction And Convenience Of Two Formulations Of Lamotrigine In Subjects With A Mood Disorder
other_psychiatry · United StatesPHASE3
other_psychiatry · United StatesPHASE3
NCT00516139Lamotrigine Extended-Release In Elderly Patients With Epilepsy
epilepsy · United StatesPHASE3
epilepsy · United StatesPHASE3
NCT01431963Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy
epilepsy · JapanPHASE3
epilepsy · JapanPHASE3
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →